Korea Debates Regenerative Meds Laws As It Looks To Keep Up
This article was originally published in PharmAsia News
Executive Summary
As South Korea seeks to establish a new law on regenerative medicines to keep pace with other countries, government and industry officials have gathered to discuss how to reinvigorate the stem cell therapy sector, designated as one of the country's new growth engines. The industry would like to see patients given early access to such therapies at hospitals even before these are formally approved.